第一作者:
Pooja Middha,Kapoor
第一单位:
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
作者:
Pooja Middha,Kapoor [1]
;
Nasim,Mavaddat [2]
;
Parichoy Pal,Choudhury [3]
;
Amber N,Wilcox [4]
;
Sara,Lindström [5]
;
Sabine,Behrens [6]
;
Kyriaki,Michailidou [7]
;
Joe,Dennis [2]
;
Manjeet K,Bolla [2]
;
Qin,Wang [2]
;
Audrey,Jung [6]
;
Zomoroda,Abu-Ful [8]
;
Thomas,Ahearn [3]
;
Irene L,Andrulis [9]
;
Hoda,Anton-Culver [10]
;
Volker,Arndt [11]
;
Kristan J,Aronson [12]
;
Paul L,Auer [13]
;
Laura E Beane,Freeman [3]
;
Heiko,Becher [14]
;
Matthias W,Beckmann [15]
;
Alicia,Beeghly-Fadiel [16]
;
Javier,Benitez [17]
;
Leslie,Bernstein [18]
;
Stig E,Bojesen [19]
;
Hiltrud,Brauch [20]
;
Hermann,Brenner [21]
;
Thomas,Brüning [22]
;
Qiuyin,Cai [16]
;
Daniele,Campa [23]
;
Federico,Canzian [24]
;
Angel,Carracedo [25]
;
Brian D,Carter [26]
;
Jose E,Castelao [27]
;
Stephen J,Chanock [3]
;
Nilanjan,Chatterjee [28]
;
Georgia,Chenevix-Trench [29]
;
Christine L,Clarke [30]
;
Fergus J,Couch [31]
;
Angela,Cox [32]
;
Simon S,Cross [33]
;
Kamila,Czene [34]
;
James Y,Dai [35]
;
H Shelton,Earp [36]
;
Arif B,Ekici [37]
;
A Heather,Eliassen [38]
;
Mikael,Eriksson [34]
;
D Gareth,Evans [39]
;
Peter A,Fasching [40]
;
Jonine,Figueroa [41]
;
Lin,Fritschi [42]
;
Marike,Gabrielson [34]
;
Manuela,Gago-Dominguez [43]
;
Chi,Gao [44]
;
Susan M,Gapstur [26]
;
Mia M,Gaudet [26]
;
Graham G,Giles [45]
;
Anna,González-Neira [46]
;
Pascal,Guénel [47]
;
Lothar,Haeberle [48]
;
Christopher A,Haiman [49]
;
Niclas,Håkansson [50]
;
Per,Hall [51]
;
Ute,Hamann [52]
;
Sigrid,Hatse [53]
;
Jane,Heyworth [54]
;
Bernd,Holleczek [55]
;
Robert N,Hoover [3]
;
John L,Hopper [56]
;
Anthony,Howell [57]
;
David J,Hunter [58]
;
ABCTB Investigators [59]
;
kConFab/AOCS Investigators [60]
;
Esther M,John [6]
;
Michael E,Jones [61]
;
Rudolf,Kaaks [62]
;
Renske,Keeman [63]
;
Cari M,Kitahara [3]
;
Yon-Dschun,Ko [59]
;
Stella,Koutros [64]
;
Allison W,Kurian [65]
;
Diether,Lambrechts [49]
;
Loic,Le Marchand [8]
;
Eunjung,Lee [62]
;
Flavio,Lejbkowicz [66]
;
Martha,Linet [67]
;
Jolanta,Lissowska [68]
;
Ana,Llaneza [69]
;
Robert J,MacInnis [70]
;
Maria Elena,Martinez [71]
;
Tabea,Maurer [18]
;
Catriona,McLean [39]
;
Susan L,Neuhausen [72]
;
William G,Newman [73]
;
Aaron,Norman [74]
;
Katie M,O'Brien [72]
;
Andrew F,Olshan [75]
;
Janet E,Olson [76]
;
Håkan,Olsson [77]
;
Nick,Orr [78]
;
Charles M,Perou [72]
;
Guillermo,Pita [35]
;
Eric C,Polley [8]
;
Ross L,Prentice [8]
;
Gad,Rennert [79]
;
Hedy S,Rennert [73]
;
Kathryn J,Ruddy [80]
;
Dale P,Sandler [60]
;
Christobel,Saunders [81]
;
Minouk J,Schoemaker [82]
;
Ben,Schöttker [72]
;
Fredrick,Schumacher [83]
;
Christopher,Scott [16]
;
Rodney J,Scott [84]
;
Xiao-Ou,Shu [85]
;
Ann,Smeets [86]
;
Melissa C,Southey [87]
;
John J,Spinelli [88]
;
Jennifer,Stone [89]
;
Anthony J,Swerdlow [90]
;
Rulla M,Tamimi [74]
;
Jack A,Taylor [91]
;
Melissa A,Troester [39]
;
Celine M,Vachon [5]
;
Elke M,van Veen [92]
;
Xiaoliang,Wang [93]
;
Clarice R,Weinberg [94]
;
Caroline,Weltens [95]
;
Walter,Willett [96]
;
Stacey J,Winham [3]
;
Alicja,Wolk [16]
;
Xiaohong R,Yang [10]
;
Wei,Zheng [97]
;
Argyrios,Ziogas [98]
;
Alison M,Dunning [99]
;
Paul D P,Pharoah [44]
;
Marjanka K,Schmidt [98]
;
Peter,Kraft [83]
;
Douglas F,Easton [3]
;
Roger L,Milne [100]
;
Montserrat,García-Closas ;
Jenny,Chang-Claude
作者单位:
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
[1]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
[2]
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[3]
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
[4]
Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.;Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[5]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[6]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.;Biostatistics Unit and the Cyprus, School of Molecular Medicine, Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
[7]
Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
[8]
Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.;Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
[9]
Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
[10]
Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[11]
Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, ON, Canada.
[12]
Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.;Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
[13]
Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.;Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
[14]
Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
[15]
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
[16]
Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.;Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[17]
Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
[18]
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
[19]
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.;Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.;iFIT-Cluster of Excellence, University of Tuebingen, Tuebingen, Germany.;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
[20]
Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), Heidelberg, Germany.;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.;Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
[21]
Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
[22]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Department of Biology, University of Pisa, Pisa, Italy.
[23]
Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[24]
Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.;Centro de Investigación en Red de Enfermedades Raras (CIBERER) y Centro Nacional de Genotipado (CEGEN-PRB2), Universidad de Santiago de Compostela, Santiago De Compostela, Spain.
[25]
Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
[26]
Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
[27]
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.;Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
[28]
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
[29]
Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
[30]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
[31]
Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
[32]
Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
[33]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
[34]
Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[35]
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
[36]
Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
[37]
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[38]
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.;North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
[39]
Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.;David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
[40]
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK.;Cancer Research UK Edinburgh Centre, Edinburgh, UK.
[41]
School of Public Health, Curtin University, Perth, Western Australia, Australia.
[42]
Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.;Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
[43]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[44]
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.;Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.;iFIT-Cluster of Excellence, University of Tuebingen, Tuebingen, Germany.;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.;Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.;Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
[45]
Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[46]
Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
[47]
Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
[48]
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
[49]
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
[50]
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.;Department of Oncology, Södersjukhuset, Stockholm, Sweden.
[51]
Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[52]
Laboratory of Experimental Oncology (LEO), Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
[53]
School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia.
[54]
Saarland Cancer Registry, Saarbrücken, Germany.
[55]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
[56]
Division of Cancer Sciences, University of Manchester, Manchester, UK.
[57]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Nuffield Department of Population Health, University of Oxford, Oxford, UK.
[58]
Division of Oncology, Departments of Epidemiology & Population Health and of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
[59]
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[60]
Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
[61]
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
[62]
Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
[63]
VIB Center for Cancer Biology, VIB, Leuven, Belgium.;Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
[64]
Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
[65]
Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
[66]
General and Gastroenterology Surgery Service, Hospital Universitario Central de Asturias, Oviedo, Spain.
[67]
Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
[68]
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.;Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
[69]
Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[70]
Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria, Australia.
[71]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
[72]
Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
[73]
Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
[74]
Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
[75]
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Ireland, UK.
[76]
Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
[77]
Human Genotyping-CEGEN Unit, Human Cancer Genetic Program, Spanish National Cancer Research Centre, Madrid, Spain.
[78]
Department of Oncology, Mayo Clinic, Rochester, MN, USA.
[79]
School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
[80]
Division of Clinical Epidemiology and Aging Research, C070, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Network Aging Research, University of Heidelberg, Heidelberg, Germany.
[81]
Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
[82]
Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.;Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.;iFIT-Cluster of Excellence, University of Tuebingen, Tuebingen, Germany.;German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.;Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.;Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.;Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia.;Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.;Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
[83]
Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.
[84]
Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.;Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.;Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
[85]
Population Oncology, BC Cancer, Vancouver, BC, Canada.;School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
[86]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.;The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia.
[87]
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.;Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
[88]
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.;Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[89]
Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.;Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
[90]
Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
[91]
Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
[92]
Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
[93]
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.;Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
[94]
Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
[95]
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.;Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
[96]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
[97]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
[98]
Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.;Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
[99]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[100]
医学主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);人体质量指数(Body Mass Index);乳腺肿瘤(Breast Neoplasms);病例对照研究(Case-Control Studies);女(雌)性(Female);疾病遗传易感性(Genetic Predisposition to Disease);人类(Humans);Logistic模型(Logistic Models);病史记录(Medical History Taking);中年人(Middle Aged);多态性, 单核苷酸(Polymorphism, Single Nucleotide);受体, 雌激素(Receptors, Estrogen);危险因素(Risk Factors)
DOI
10.1093/jnci/djaa056
PMID
32359158
发布时间
2026-04-05
- 浏览0
Journal of the National Cancer Institute
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文





换一批



